[CytoReason in Mobi Health News] Israeli startup CytoReason joins forces with Ferring Pharmaceuticals to find new IBD treatment
Israeli startup CytoReason today announced a partnership with Swiss multinational, Ferring Pharmaceuticals, to establish new treatments for inflammatory bowel disease (IBD). Read...
Read More